Tyra Biosciences, Inc.
Tyra Biosciences, Inc. (TYRA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TYRA · as of Jun 9, 2026
Key Statistics
Explore Tyra Biosciences, Inc. Data
tyra stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The TYRA analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $50.50, representing +88.79% upside from the current price of $26.75.
Competitors & Peers
tyra competitorsTYRA
DAWN
EYPT
GERN
KURA
MRVIStock Performance
Full HistoryAbout Tyra Biosciences, Inc.
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, …
what is tyra biosciences, inc. · tyra stock overview · tyra biosciences, inc. company profile · who is tyra biosciences, inc. ceo · tyra NASDAQ · tyra biosciences, inc. headquarters · tyra biosciences, inc. business segments
About Stock Overview & Key Data
Tyra Biosciences, Inc. (TYRA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2021. As of the latest trading session, TYRA stock price is $26.75, with a market capitalization of $1.6B. The stock has returned +160.72% over the past 12 months and +1.75% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Tyra Biosciences, Inc. stock is Buy, with an average 12-month price target of $50.50. In fiscal year 2025, Tyra Biosciences, Inc. reported revenue of — and net income of -$119.9M. For detailed data — including Tyra Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Tyra Biosciences, Inc. (TYRA) stock price is $26.75. The stock is traded on NASDAQ under the ticker symbol TYRA. The 52-week range is $8.98 – $40.65.